Nano‐Backpack Engineered Probiotics with Reactive Oxygen Species–Responsive Tungsten Release for Synergistic Therapy of Inflammatory Bowel Disease
Advanced Science · 2026
DOI: 10.1002/advs.76291 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Yang Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Probiotics, Inflammatory Bowel Diseases, Tungsten. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Chongqing Medical Scientific Research Project.
Abstract (Originalsprache)
Integrating probiotics with functional nanomaterials to disrupt the cycle of gut microbiota dysbiosis and reactive oxygen species (ROS) overload is an emerging therapeutic strategy for inflammatory bowel disease (IBD). However, simplistic combinations of therapeutics often result in spatiotemporal mismatch within the gastrointestinal tract, preventing precise intervention at target inflammatory sites. To address this, a composite probiotic system, BSCS@WO 3 @PDA is developed, centered around programmed ROS‐mediated cascade regulation for intelligent synergistic therapeutic intervention. The system is constructed by electrostatic assembly of polydopamine (PDA)‐coated tungsten trioxide nanoparticles onto chitosan‐encapsulated Bacillus subtilis (BS), thereby significantly enhancing gastrointestinal stability and promoting prolonged retention in the inflamed colon. At the inflammatory site, the ROS‐responsive PDA shell enabled on‐demand ROS scavenging while undergoing degradation, leading to the sustained release of tungsten ions. These ions specifically inhibited molybdenum cofactor‐dependent nitrate reductase activity in Enterobacteriaceae metabolism, thereby creating a favorable ecological niche for probiotics. Consequently, the retained BS promoted beneficial microbes and metabolites, reversing colitis‐associated metabolic disorders and synergistically enhancing intestinal barrier repair. This study proposes a novel paradigm of precise cascade metabolic regulation by integrating ROS scavenging and pathogen inhibition. The BSCS@WO 3 @PDA system offers a powerful new strategy for restoring gut microecological homeostasis and treating inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chongqing Medical University, Chongqing, China.
- Department of General Surgery, Chongqing Academy of Medical Sciences, Chongqing General Hospital, Chongqing University, Chongqing, China.
- Key Laboratory of Biorheological Science and Technology, College of Bioengineering, Ministry of Education, Chongqing University, Chongqing, China.
ORCID-Profile: Min Yu, Jixi Zhang
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Chongqing Medical Scientific Research Project
Zitieren
APA
Yang, Y., Wang, L., Chen, G., Zhang, Y., Shi, J., Fan, W., Yu, M., Zhang, J., & Yang, H. (2026). Nano‐Backpack Engineered Probiotics with Reactive Oxygen Species–Responsive Tungsten Release for Synergistic Therapy of Inflammatory Bowel Disease. Advanced Science. https://doi.org/10.1002/advs.76291
Vancouver
Yang Y, Wang L, Chen G, Zhang Y, Shi J, Fan W, et al. Nano‐Backpack Engineered Probiotics with Reactive Oxygen Species–Responsive Tungsten Release for Synergistic Therapy of Inflammatory Bowel Disease. Advanced Science. 2026. doi:10.1002/advs.76291
BibTeX
@article{Yang2026,
author = {Yang, Yang and Wang, Liucan and Chen, Guoqing and Zhang, Yuanling and Shi, Jiarui and Fan, Wenzhe and Yu, Min and Zhang, Jixi and Yang, Hua},
title = {Nano‐Backpack Engineered Probiotics with Reactive Oxygen Species–Responsive Tungsten Release for Synergistic Therapy of Inflammatory Bowel Disease},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.76291}
}
EUVIMED